Skip to main content

Peer Review reports

From: Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

Original Submission
4 Sep 2020 Submitted Original manuscript
15 Jul 2021 Reviewed Reviewer Report - Rhiannon Macefield
28 Sep 2021 Reviewed Reviewer Report - Stephen J Chapman
24 Nov 2021 Author responded Author comments - Olalekan Lee Aiyegbusi
Resubmission - Version 2
24 Nov 2021 Submitted Manuscript version 2
11 Dec 2021 Reviewed Reviewer Report - Stephen J Chapman
15 Dec 2021 Reviewed Reviewer Report - Rhiannon Macefield
19 Dec 2021 Author responded Author comments - Olalekan Lee Aiyegbusi
Resubmission - Version 3
19 Dec 2021 Submitted Manuscript version 3
Publishing
4 Jan 2022 Editorially accepted
15 Jan 2022 Article published 10.1186/s13063-022-06000-w

You can find further information about peer review here.

Back to article page